Lahore: Citi Pharma Limited has announced it will hold its Annual General Meeting (AGM) on October 28, 2024. The meeting will take place at Lahore, and will also be accessible via video conference. This meeting aims to address key financial and operational strategies for the year.

Members of the company are set to confirm the minutes from the previous AGM held on October 27, 2023. There will be a focus on the audited financial statements of the company for the fiscal year that ended on June 30, 2024, including directors’ and auditors’ reports. These documents will be available for viewing and download through a provided weblink and QR code.

According to information available from the Pakistan Stock Exchange (PSX), the agenda includes appointing the statutory auditors for the next term, with the current auditors M/s Aslam Malik and Co. Chartered Accountants offering themselves for reappointment. Their remuneration will be agreed upon mutually and will cover necessary expenses.

Furthermore, the board proposes a final cash dividend of Rs. 3.25 per share, marking a 32.5% yield for the fiscal year. This recommendation is awaiting shareholder approval during the meeting.

Citi Pharma continues to focus on transparent governance and shareholder engagement, as evidenced by the thorough preparation and structured agenda of the upcoming AGM.